Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.

Bell MT, Agoston VA, Freeman KA, Puskas F, Herson PS, Mares J, Fullerton DA, Reece TB. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia. J Vasc Surg. 2014 Apr; 59(4):1090-7.

View in: PubMed

subject areas

Adrenergic alpha-2 Receptor Agonists
Animals
Anti-Inflammatory Agents
Aorta, Thoracic
Cell Survival
Cells, Cultured
Cytokines
Dexmedetomidine
Disease Models, Animal
Inflammation Mediators
Ligation
Lipopolysaccharides
Male
Mice
Mice, Inbred C57BL
Microglia
Neuroprotective Agents
Paraplegia
Receptors, Adrenergic, alpha-2
Signal Transduction
Spinal Cord
Time Factors
Toll-Like Receptor 4

authors with profiles

T. Brett Reece
Paco Sam Herson